CRL
Charles River Laboratories International Inc
Price:  
221.61 
USD
Volume:  
927,644.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRL WACC - Weighted Average Cost of Capital

The WACC of Charles River Laboratories International Inc (CRL) is 9.4%.

The Cost of Equity of Charles River Laboratories International Inc (CRL) is 10.75%.
The Cost of Debt of Charles River Laboratories International Inc (CRL) is 4.30%.

Range Selected
Cost of equity 9.40% - 12.10% 10.75%
Tax rate 17.20% - 17.70% 17.45%
Cost of debt 4.00% - 4.60% 4.30%
WACC 8.3% - 10.5% 9.4%
WACC

CRL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.2 1.28
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.40% 12.10%
Tax rate 17.20% 17.70%
Debt/Equity ratio 0.23 0.23
Cost of debt 4.00% 4.60%
After-tax WACC 8.3% 10.5%
Selected WACC 9.4%